EMEA-000275-PIP01-08
Key facts
Active substance |
Rolofylline
|
Therapeutic area |
Cardiovascular diseases
|
Decision number |
P/87/2009
|
PIP number |
EMEA-000275-PIP01-08
|
Pharmaceutical form(s) |
Emulsion for injection
|
Condition(s) / indication(s) |
Heart Failure
|
Route(s) of administration |
Intravenous use
|
Contact for public enquiries |
Merck Sharp & Dohme (Europe), Inc.
E-mail: axel_breitstadt@merck.com |
Decision type |
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)
|